FDA Approved: LORATADINE ANTIHISTAMINE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)

View source ↗

Summary

FDA approves a supplemental labeling application for loratadine antihistamine from Padagis Israel Pharmaceuticals Ltd, resulting in updated labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Idiopathic Urticaria

Drugs mentioned

• Loratadine (Loratadine)

Snippet

SUPPL AP for LORATADINE ANTIHISTAMINE (LORATADINE)